Breadcrumb AMCP.org Resource Center Topics Biosimilars AMCP submits letter to Vermont House Committee on Health Care regarding Senate Bill 92 on Substitution of Interchangeable Biologic Products Tweet this pagePost this page on FacebookPost this page on LinkedInEmail this pagePrint this page 2/28/18 AMCP submits letter to Vermont House Committee on Health Care regarding Senate Bill 92 on Substitution of Interchangeable Biologic Products AMCP submits letter to Vermont House Committee on Health Care regarding Senate Bill 92 on Substitution of Interchangeable Biologic Products.pdf Tags: Biosimilars (52) Formulary Management (12) Legislation & Regulation (17) Managed Care Practice Issues (17) Tweet this pagePost this page on FacebookPost this page on LinkedInEmail this pagePrint this page